Vivani Medical Mergers and Acquisitions Presentation Deck

Orion II Current Activities and Future Considerations • Initial clinical pilot study at UCLA and Baylor College of Medicine; 3-year data encouraging . Confirming regulatory pathway with FDA • Patient Preference Study - Part one - informs potential adoption; encouraging results obtained • Patient Preference Study - Part two - defines safety endpoints for approval; in preparation • Market Access, Reimbursement and Long-term Support Programs critical for long-term success • New Leadership Team is developing strategic options for advancing Orion II 22

View entire presentation